Search…

Hengrui Medicine (01276.HK): Perfluorohexyl octane eye drops approved for market listing.

04/07/2025

Zhongtong Finance App News, Hengrui Medicine (01276.HK) announced that recently, its subsidiary Chengdu Shengdi Medicine Co., Ltd. received a notification from the National Medical Products Administration approving the launch of the company's product perfluorohexane eye drops for the treatment of meibomian gland dysfunction (MGD)-related dry eye.

Latest

3 m ago

Federal Reserve official Bostic: Forward guidance will not be effective in the current environment.

5 m ago

Federal Reserve's Boston: Debt issues may cause interest rate trends to be independent of Federal Reserve policy measures.

6 m ago

Morgan Stanley: The potential chip manufacturing process change for Intel has very little impact on its financial situation.

6 m ago

Morgan Stanley: Intel's potential chip manufacturing process change has a minimal impact on its financial situation.

7 m ago

A senior executive at Citigroup revealed that despite the UK increasing taxes on the wealthy, it still attracts attention from affluent clients who are disappointed in the United States. "For clients both inside and outside the UK, this is a two-way flow," said Andy Sieg, global wealth manager at Citigroup. He added that while some people are leaving the UK, others are "looking at the United States and the changes happening there and thinking that the UK might be a place where their children may want to go to university and where they would be willing to spend more time."

See all latest